The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,824.00
Bid: 1,816.00
Ask: 1,826.00
Change: -16.00 (-0.87%)
Spread: 10.00 (0.551%)
Open: 1,870.00
High: 1,870.00
Low: 1,814.00
Prev. Close: 1,840.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition of Génétiporc

18 Oct 2013 07:00

RNS Number : 8135Q
Genus PLC
18 October 2013
 



For Immediate Release

18 October 2013

 

 

Genus plc

("Genus")

 

Completion of Acquisition of Génétiporc

 

Genus, a leading global animal genetics company, is pleased to confirm that, further to the announcement on 23 September 2013, it has now completed the acquisition of Génétiporc, the porcine genetics business of Aliments Breton Foods Group, the largest producer and processor of organic and natural pork in North America.  Discussions continue regarding the acquisition by Agroceres PIC, Genus's 49% owned joint venture in Brazil, of Génétiporc's Brazilian joint venture, following the memorandum of understanding agreed in September 2013. 

 

Génétiporc represents an excellent strategic fit with Genus's core activities and has very similar values to Genus's porcine global business unit, PIC. Génétiporc has a strong reputation across the Americas for porcine genetics with a particular emphasis on meat quality, product development, bio-security and health, all of which are also areas of focus for Genus. The acquisition will bring significant opportunities from the combination of the two operations and will further strengthen PIC's market position.

 

 

For further information please contact:

 

Genus plc

Tel: 01256 345970

Karim Bitar, Chief Executive

 

Stephen Wilson, Group Finance Director

 

 

 

 

Buchanan

Tel: 0207 466 5000

Charles Ryland /Sophie McNulty

 

 

This announcement is available on the Genus website www.genusplc.com

 

 

About Genus

Genus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across all livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.

 

Genus's worldwide sales are made in seventy countries under the trademarks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Genus' customers' animals produce offspring with greater production efficiency, and quality, and use these to supply the global dairy and meat supply chain.

 

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.

 

With headquarters in Basingstoke, United Kingdom, Genus companies operate in thirty countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

About Génétiporc

Génétiporc is the porcine breeding business of Aliments Breton Foods Group. It is based in Canada with operations in the US and Mexico and a joint venture in Brazil.

 

Founded in 1984, in response to demand from producers for a swine genetics company that would understand their concerns and would be there to offer solutions, Génétiporc is now one of the leading providers of porcine genetics in North America. It prides itself on its achievements in product development, health and biosecurity and meat quality.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFLAITLDLIV
Date   Source Headline
24th Feb 20067:01 amRNSDisposal
31st Jan 20065:06 pmRNSAdditional Listing
10th Jan 20063:12 pmRNSAdditional Listing
15th Dec 20056:34 pmRNSHolding(s) in Company
15th Dec 20056:20 pmRNSHolding(s) in Company
7th Dec 20057:01 amRNSDirectors' Share Awards
2nd Dec 20058:38 amRNSOffer Update
29th Nov 20057:02 amRNSInterim Results
25th Nov 200512:54 pmRNSOffer Update
22nd Nov 20057:02 amRNSOffer Update
18th Nov 20059:16 amRNSSchedule 1 - Genus PLC
14th Nov 200512:51 pmRNSOffer Update
11th Nov 20054:15 pmRNSRule 8.1- (Sygen)
8th Nov 20052:05 pmRNSOffer Update
4th Nov 20052:40 pmRNSRule 8.1- (Sygen)
3rd Nov 200512:48 pmRNSOffer Update
3rd Nov 20057:00 amRNSNotice of Interim Results
2nd Nov 20055:20 pmRNSRule 8.1- (Sygen)
2nd Nov 200510:19 amRNSOffer Update
1st Nov 20056:05 pmRNSRule 8.1- (Sygen)
1st Nov 200512:59 pmRNSOffer Document Posted
28th Oct 20055:48 pmRNSDisposal
28th Oct 20057:01 amRNSOffer for Sygen Int. plc
10th Oct 20057:00 amRNSPre-Close Trading Update
18th Aug 20054:13 pmRNSResult of AGM
18th Aug 20057:00 amRNSAGM Statement
19th Jul 200511:36 amRNSIssue of Equity
12th Jul 200512:31 pmRNSIssue of Equity
20th Jun 200511:37 amRNSIssue of Equity
8th Jun 20052:33 pmRNSIssue of Equity
24th May 20057:01 amRNSFinal Results
4th May 20054:59 pmRNSNotice of Results
2nd Mar 20055:33 pmRNSDirector Shareholding
19th Jan 20058:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.